uniQure: AMT-130 Gene Therapy Slows Progression of Huntington’s Disease
A dose-dependent slowing in Huntington's disease progression was observed after 24 months in patients receiving high-dose AMT-130. The gene therapy ...
A dose-dependent slowing in Huntington's disease progression was observed after 24 months in patients receiving high-dose AMT-130. The gene therapy ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.